Cargando…
Personality traits favourable for non-adherence to treatment in patients with chronic myeloid leukaemia: role of type A and D personality
BACKGROUND: The introduction of BCR-ABL tyrosine kinase inhibitors (TKIs) to chronic myeloid leukemia (CML) therapy has revolutionized the treatment of this disease. Although regular TKI intake is a prerequisite for successful therapy, it has been shown that a significant proportion of patients are...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854114/ https://www.ncbi.nlm.nih.gov/pubmed/36658586 http://dx.doi.org/10.1186/s13030-023-00261-w |